Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-031641

Director acquired 600,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ultragenyx Pharmaceutical Inc. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-05-20 Exercise or conversion : show line 1 in the form +600,000 $16.00 $9,600,000 3,000,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-20 Exercise or conversion : show line 2 in the form Option (Right to Buy) −600,000 0 D
Loading xslF345X03/doc4.xml…